Email -: [email protected]
Phone : +91 96186 21283
Designation -: Affiliation: President &Chief Technology Officer (CTO),
Company : Jodas Expoim Pvt Ltd, Hyderabad India
Dr. Tathagata Dutta holds a B.Pharm.,M.Pharm, and PhD in Pharmaceutical Sciences from Dr. Hari Singh Gour University, Sagar. He further pursued postdoctoral studies at the School of Pharmacy & Diamantina Institute for Cancer, Immunology, and Metabolic Medicine, University of Queensland, Brisbane, Australia, focusing on the development of RNAi therapeutics for cancer management. Additionally, he is an alumnus of IIM Calcutta.
Over the span of more than two decades, Dr. Dutta has held various esteemed positions, including President, Chief Scientific Officer (CSO), Vice President (R&D), Executive Director, Managing Director & CEO, within several reputable multinational pharmaceutical companies worldwide. His contributions to the field have been recognized with numerous National and International Awards and Honors.
Dr. Dutta's research endeavors have led to the publication of several papers in renowned international journals, numerous patents, and authored book chapters. He serves as an editorial board member for several international journals focusing on drug discovery & delivery research.
His research interests span a wide array of topics, including novel drug delivery systems, dendrimers, liposomes, polymer bioconjugates, tissue-targeted drug delivery systems, nanodrug delivery systems, gene therapy, vaccines, genetic immunization, depot injections, gene delivery, and the development of RNAi therapeutics.